Cargando…
Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice
BACKGROUND: Mesenchymal stem cell (MSC) transplantation has emerged as a promising therapy for liver fibrosis. Issues concerning poor MSC survival and engraftment in the fibrotic liver still persist and warrant development of a strategy to increase MSC potency for liver repair. The present study was...
Autores principales: | Nasir, Ghazanfar Ali, Mohsin, Sadia, Khan, Mohsin, Shams, Sulaiman, Ali, Gibran, Khan, Shaheen N, Riazuddin, Sheikh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636128/ https://www.ncbi.nlm.nih.gov/pubmed/23531302 http://dx.doi.org/10.1186/1479-5876-11-78 |
Ejemplares similares
-
Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis
por: Ali, Gibran, et al.
Publicado: (2012) -
Mesenchymal Stem Cells Pretreated with HGF and FGF4 Can Reduce Liver Fibrosis in Mice
por: Shams, Sulaiman, et al.
Publicado: (2015) -
Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice
por: Khan, Mohsin, et al.
Publicado: (2011) -
Mesenchymal stem cells conditioned with glucose depletion augments their ability to repair-infarcted myocardium
por: Choudhery, Mahmood S, et al.
Publicado: (2012) -
Preconditioning diabetic mesenchymal stem cells with myogenic medium increases their ability to repair diabetic heart
por: Khan, Mohsin, et al.
Publicado: (2013)